Lundbeckfond Invest A/S 13D/13G Filings for Trevi Therapeutics, Inc. (TRVI)

Lundbeckfond Invest A/S 13D and 13G filings for Trevi Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2022-01-26
4:15 pm
Unchanged		2021-12-3113GTrevi Therapeutics, Inc.
TRVI		Lundbeckfond Invest A/S 1,151,544
4.500%		0
(Unchanged)		Filing